ATE113949T1 - Alpha-adrenergische rezeptorantagonisten. - Google Patents
Alpha-adrenergische rezeptorantagonisten.Info
- Publication number
- ATE113949T1 ATE113949T1 AT89305338T AT89305338T ATE113949T1 AT E113949 T1 ATE113949 T1 AT E113949T1 AT 89305338 T AT89305338 T AT 89305338T AT 89305338 T AT89305338 T AT 89305338T AT E113949 T1 ATE113949 T1 AT E113949T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- receptor antagonists
- antagonists
- adrenegic
- adrenegic receptor
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 102000015007 alpha-adrenergic receptor activity proteins Human genes 0.000 abstract 3
- 108040006816 alpha-adrenergic receptor activity proteins Proteins 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 3
- 230000008485 antagonism Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20100488A | 1988-06-01 | 1988-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE113949T1 true ATE113949T1 (de) | 1994-11-15 |
Family
ID=22744083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89305338T ATE113949T1 (de) | 1988-06-01 | 1989-05-26 | Alpha-adrenergische rezeptorantagonisten. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0344979B1 (de) |
| JP (1) | JPH03504607A (de) |
| KR (1) | KR900701797A (de) |
| CN (1) | CN1039810A (de) |
| AT (1) | ATE113949T1 (de) |
| AU (1) | AU629224B2 (de) |
| CA (1) | CA1320953C (de) |
| DE (1) | DE68919280T2 (de) |
| NZ (1) | NZ229300A (de) |
| PT (1) | PT90719B (de) |
| WO (1) | WO1989012054A1 (de) |
| ZA (1) | ZA894098B (de) |
| ZW (1) | ZW6789A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2107644A1 (en) * | 1992-10-28 | 1994-04-29 | David R. Magnin | .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd |
| US5712396A (en) * | 1992-10-28 | 1998-01-27 | Magnin; David R. | α-phosphonosulfonate squalene synthetase inhibitors |
| FR2708612B1 (fr) * | 1993-08-05 | 1996-03-01 | Roussel Uclaf | Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant. |
| US5447922A (en) * | 1994-08-24 | 1995-09-05 | Bristol-Myers Squibb Company | α-phosphonosulfinic squalene synthetase inhibitors |
| EP1939180A1 (de) * | 2006-12-20 | 2008-07-02 | sanofi-aventis | Heteroarylacrylamide und ihre Verwendung als Arzneimittel für die Stimulation der Expression der endothelialen NO-Synthase |
| US9556200B2 (en) | 2012-03-06 | 2017-01-31 | Takeda Pharmaceutical Company Limited | Tricyclic compound |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856910A (en) * | 1950-01-10 | 1974-12-24 | Roussel Uclaf | Novel thienobenzazepines as anti-depressants |
| US3649644A (en) * | 1969-08-08 | 1972-03-14 | Warner Lambert Co | 1 2 3 4 4a 5 6 6a-octahydrobenzofuro (3 2-c)indoles |
| BE795451A (fr) * | 1972-02-23 | 1973-08-16 | Pfizer | Agents hypoglycemiants aza indoliques tricycliques |
| US3950343A (en) * | 1973-11-06 | 1976-04-13 | Ayerst, Mckenna And Harrison Ltd. | Pyrroloisoquinoline derivatives |
| JPS57144286A (en) * | 1981-03-02 | 1982-09-06 | Takeda Chem Ind Ltd | Azepinoindole derivative and its preparation |
| US4833244A (en) * | 1985-04-22 | 1989-05-23 | Hoechst-Rouseel Pharmaceuticals Inc. | Ethanobenzazepines |
| DE3525564A1 (de) * | 1985-07-15 | 1987-02-05 | Schering Ag | Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| US4769368A (en) * | 1986-02-10 | 1988-09-06 | Smithkline Beckman Corporation | 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines |
| DE3630539A1 (de) * | 1986-09-08 | 1988-03-10 | Madaus & Co Dr | Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten |
-
1989
- 1989-05-26 CA CA000600795A patent/CA1320953C/en not_active Expired - Fee Related
- 1989-05-26 NZ NZ229300A patent/NZ229300A/xx unknown
- 1989-05-26 AT AT89305338T patent/ATE113949T1/de not_active IP Right Cessation
- 1989-05-26 DE DE68919280T patent/DE68919280T2/de not_active Expired - Fee Related
- 1989-05-26 EP EP89305338A patent/EP0344979B1/de not_active Expired - Lifetime
- 1989-05-29 ZW ZW67/89A patent/ZW6789A1/xx unknown
- 1989-05-30 ZA ZA894098A patent/ZA894098B/xx unknown
- 1989-05-31 AU AU38572/89A patent/AU629224B2/en not_active Ceased
- 1989-05-31 WO PCT/US1989/002396 patent/WO1989012054A1/en not_active Ceased
- 1989-05-31 JP JP1507325A patent/JPH03504607A/ja active Pending
- 1989-05-31 CN CN89103836A patent/CN1039810A/zh active Pending
- 1989-05-31 KR KR1019900700203A patent/KR900701797A/ko not_active Ceased
- 1989-06-01 PT PT90719A patent/PT90719B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0344979A3 (de) | 1991-05-15 |
| AU629224B2 (en) | 1992-10-01 |
| EP0344979B1 (de) | 1994-11-09 |
| EP0344979A2 (de) | 1989-12-06 |
| WO1989012054A1 (en) | 1989-12-14 |
| DE68919280T2 (de) | 1995-03-23 |
| KR900701797A (ko) | 1990-12-04 |
| ZA894098B (en) | 1990-06-27 |
| ZW6789A1 (en) | 1989-08-30 |
| NZ229300A (en) | 1991-04-26 |
| AU3857289A (en) | 1990-01-05 |
| DE68919280D1 (de) | 1994-12-15 |
| PT90719A (pt) | 1989-12-29 |
| CA1320953C (en) | 1993-08-03 |
| PT90719B (pt) | 1994-11-30 |
| CN1039810A (zh) | 1990-02-21 |
| JPH03504607A (ja) | 1991-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69034103D1 (de) | Imidazoalkensäure | |
| SE8505112D0 (sv) | Novel pharmacological compounds | |
| ES2138977T3 (es) | Agonistas muscarinicos. | |
| ES2172580T3 (es) | 1,3-oxatiolanos sustituidos con propiedades antiviricas. | |
| FI905481A0 (fi) | Substituerade n-(imidazolyl) -alkylalaninderivat. | |
| FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
| ATE113949T1 (de) | Alpha-adrenergische rezeptorantagonisten. | |
| FI881609A0 (fi) | Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| ES2067541T3 (es) | Mejoras en antagonistas de la serotonina y relacionadas con ellos. | |
| FI891473A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi | |
| ATE114310T1 (de) | Alpha-adrenergische rezeptorantagonisten. | |
| ES2044100T3 (es) | Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos. | |
| ATE109483T1 (de) | Alpha-adrenergische rezeptorantagonisten. | |
| EP0344980A3 (de) | Alpha-adrenergische Rezeptorantagonisten | |
| FI873145A0 (fi) | Nya tetracykliska indolderivat. | |
| ES2032838T3 (es) | Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |